Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB.
Animals
Apoptosis
/ drug effects
Cell Survival
/ drug effects
Cells, Cultured
Gene Expression Regulation
/ drug effects
I-kappa B Kinase
/ genetics
Mice, Inbred C57BL
Mice, Knockout
NF-kappa B
/ genetics
Receptor-Interacting Protein Serine-Threonine Kinases
/ genetics
Signal Transduction
/ drug effects
Thymocytes
/ cytology
Transcription Factor RelA
/ genetics
Tumor Necrosis Factor-alpha
/ pharmacology
RIPK1
TNF
inhibitor of kappa-B kinase
nuclear factor kappa-B
thymocyte
Journal
Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918
Informations de publication
Date de publication:
19 02 2019
19 02 2019
Historique:
received:
19
03
2018
revised:
07
11
2018
accepted:
04
01
2019
pubmed:
10
2
2019
medline:
14
8
2019
entrez:
10
2
2019
Statut:
ppublish
Résumé
NF-κB (nuclear factor κB) signaling is considered critical for single positive (SP) thymocyte development because loss of upstream activators of NF-κB, such as the IKK complex, arrests their development. We found that the compound ablation of RelA, cRel, and p50, required for canonical NF-κB transcription, had no impact upon thymocyte development. While IKK-deficient thymocytes were acutely sensitive to tumor necrosis factor (TNF)-induced cell death, Rel-deficient cells remained resistant, calling into question the importance of NF-κB as the IKK target required for thymocyte survival. Instead, we found that IKK controlled thymocyte survival by repressing cell-death-inducing activity of the serine/threonine kinase RIPK1. We observed that RIPK1 expression was induced during development of SP thymocytes and that IKK was required to prevent RIPK1-kinase-dependent death of SPs in vivo. Finally, we showed that IKK was required to protect Rel-deficient thymocytes from RIPK1-dependent cell death, underscoring the NF-κB-independent function of IKK during thymic development.
Identifiants
pubmed: 30737145
pii: S1074-7613(19)30004-4
doi: 10.1016/j.immuni.2019.01.004
pmc: PMC6382466
pii:
doi:
Substances chimiques
NF-kappa B
0
Transcription Factor RelA
0
Tumor Necrosis Factor-alpha
0
Receptor-Interacting Protein Serine-Threonine Kinases
EC 2.7.11.1
Ripk1 protein, mouse
EC 2.7.11.1
I-kappa B Kinase
EC 2.7.11.10
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
348-361.e4Subventions
Organisme : Medical Research Council
ID : MC_PC_13055
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P011225/1
Pays : United Kingdom
Informations de copyright
Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.
Références
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7753-8
pubmed: 24821786
Eur J Immunol. 2003 Feb;33(2):314-25
pubmed: 12548562
Nat Immunol. 2006 Aug;7(8):851-8
pubmed: 16799562
Cell. 2008 May 16;133(4):693-703
pubmed: 18485876
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11677-82
pubmed: 16857737
BMC Dev Biol. 2001;1:4
pubmed: 11299042
EMBO J. 2012 Feb 1;31(3):692-706
pubmed: 22124325
J Exp Med. 2003 Apr 7;197(7):861-74
pubmed: 12668645
Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14
pubmed: 20823910
J Immunol. 2018 Jan 1;200(1):271-285
pubmed: 29167229
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7397-402
pubmed: 24799710
Bioorg Med Chem Lett. 2006 Jan 1;16(1):108-12
pubmed: 16236504
J Exp Med. 2016 Jul 25;213(8):1399-407
pubmed: 27432943
J Exp Med. 2009 Dec 21;206(13):3001-14
pubmed: 19995950
Cell Cycle. 2016;15(1):5-6
pubmed: 26516792
Sci Signal. 2011 Nov 15;4(199):ra77
pubmed: 22087033
Cell. 2014 May 22;157(5):1175-88
pubmed: 24813849
J Immunol. 2003 May 1;170(9):4630-7
pubmed: 12707341
Cell. 2014 May 22;157(5):1189-202
pubmed: 24813850
Trends Immunol. 2004 Jun;25(6):280-8
pubmed: 15145317
Nature. 2015 Jan 15;517(7534):311-20
pubmed: 25592536
Nat Cell Biol. 2007 Apr;9(4):461-9
pubmed: 17351639
Trends Immunol. 2016 Aug;37(8):535-545
pubmed: 27424290
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):E846-55
pubmed: 24550492
Immunity. 1998 Mar;8(3):297-303
pubmed: 9529147
Cell. 2003 Jul 25;114(2):181-90
pubmed: 12887920
Immunity. 2003 Sep;19(3):377-89
pubmed: 14499113
FASEB J. 2015 Feb;29(2):443-54
pubmed: 25376833
Cell Death Differ. 2009 Sep;16(9):1279-88
pubmed: 19373245
Sci Signal. 2010 Mar 30;3(115):re4
pubmed: 20354226
Immunity. 2008 Oct 17;29(4):523-37
pubmed: 18957265
Nat Commun. 2017 Aug 25;8(1):359
pubmed: 28842570
Nat Commun. 2016 Nov 18;7:13353
pubmed: 27857075
Nat Immunol. 2016 May;17(5):565-73
pubmed: 27043411
Mol Cell. 2015 Oct 1;60(1):63-76
pubmed: 26344099
Trends Mol Med. 2018 Jan;24(1):49-65
pubmed: 29217118
Immunity. 2000 Nov;13(5):677-89
pubmed: 11114380
Eur J Immunol. 1999 Sep;29(9):2968-80
pubmed: 10508271
Immunol Cell Biol. 2015 Apr;93(4):406-16
pubmed: 25601273
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4566-71
pubmed: 15070758
J Exp Med. 2011 Apr 11;208(4):633-41
pubmed: 21402742
Biochem J. 2011 Feb 15;434(1):93-104
pubmed: 21138416
Science. 2014 Mar 21;343(6177):1357-60
pubmed: 24557836
Nat Rev Immunol. 2011 Dec 23;12(2):79-88
pubmed: 22193709
J Immunol. 2000 Nov 1;165(9):5004-10
pubmed: 11046028
Cell Death Differ. 2013 Oct;20(10):1381-92
pubmed: 23892367